Christine Dolan

Insider Reports History

Entity
Individual
Location
C/O Maravai Lifesciences Holdings, Inc., 10770 Wateridge Circle Suite 200, San Diego, CA
Signature
/s/ Kurt Oreshack, by power of attorney for Christine Dolan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Dolan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MARAVAI LIFESCIENCES HOLDINGS, INC. Executive Vice President & General Manager, Cygnus Technologies Class A Common Stock 258K $1.47M $5.70 Apr 30, 2024 Direct

Insider Reports Filed by Christine Dolan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Apr 30, 2024 1 $2.75K 4 May 2, 2024 Executive Vice President & General Manager, Cygnus Technologies
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Mar 15, 2024 1 -$41.4K 4 Mar 18, 2024 Executive Vice President & General Manager, Cygnus Technologies
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Feb 15, 2024 1 -$10.6K 4 Feb 20, 2024 Executive Vice President & General Manager, Cygnus Technologies
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Jan 16, 2024 1 $0 4 Jan 18, 2024 Executive Vice President & General Manager, Cygnus Technologies
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Oct 31, 2023 1 $10.1K 4 Nov 16, 2023 Chief Operating Officer, Biologics Safety Testing
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Apr 28, 2023 1 $16.3K 4 Jul 19, 2023 Chief Operating Officer, Biologics Safety Testing
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Mar 15, 2023 2 $0 4 Mar 17, 2023 Chief Operating Officer, Biologics Safety Training
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Feb 15, 2023 1 -$29.8K 4 Feb 17, 2023 Chief Operating Officer, Biologics Safety Testing
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Apr 29, 2022 1 $15.3K 4 Jun 27, 2022 Chief Operating Officer, Biologics Safety Testing
MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. Jan 25, 2022 4 $25.7K 4 Jan 27, 2022 Chief Operating Officer, Biologics Safety Training